Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
The BJP appears to be clueless as to how to handle the people’s fury and the Opposition’s mega rally at...
Read moreDetails
By Aakar Patel My thesis is that the Indian state under Hindutva is incompletely communal. I have written about this...
Read moreDetails
By Dilip Cherian The litany of extensions continues. The latest is Defence Secretary Rajesh Kumar Singh, whose tenure the Modi...
Read moreDetails
The angry young generation is rising in protest in India, France, Spain, Italy, Germany, Poland and Serbia, to name a...
Read moreDetails
